Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
ESPERITE (ESP) : L1 Capital subscribes to the 14th tranche of investment today | ||
By: Nasdaq / GlobeNewswire - 31 Jan 2018 | Back to overview list |
|
Amsterdam, The Netherlands - 31 January 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the 14th Tranche of EUR 250,000 is issued as a private placement of 25 convertible notes (the "Notes") with a principal amount of EUR 10,000 each, with 206,801 share subscription warrants attached (the "Warrants"), under the financing agreement of up to EUR 13.0 million signed between the Group and the European Select Growth Opportunities Fund on 8 March 2017 (the "Agreement"). About ESPERITE ESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and precision medicine founded in 2000. *** This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation). With respect to Member States of the European Economic Area that have transposed European Directive 2003/71/EC of the European Parliament and European Council (as amended in particular by Directive 2010/73/EU to the extent that the said Directive has been transposed into each Member State of the European Economic Area), no action has been taken or will be taken to permit a public offering of the securities referred to in this press release requiring the publication of a prospectus in any Member State. http://www.globenewswire.com/NewsRoom/AttachmentNg/de628467-a97a-4011-bb2c-8b3168591ed6 |
||
|
||
Copyright 2018 Nasdaq / GlobeNewswire | Back to overview list |